-
Sarkozy released from jail 'nightmare' pending appeal trial
-
COP30 has a mascot: the fiery-haired guardian of Brazil's forest
-
The Sudanese who told the world what happened in El-Fasher
-
Three things we learned from the Sao Paulo Grand Prix
-
ASC acquire majority share in Atletico Madrid
-
Ferrari boss tells Hamilton, Leclerc to drive, not talk
-
Bank of England seeks to 'build trust' in stablecoins
-
China suspends 'special port fees' on US vessels for one year
-
French court frees ex-president Sarkozy from jail pending appeal
-
No link between paracetamol and autism, major review finds
-
Typhoon Fung-wong floods Philippine towns, leaves 5 dead in its wake
-
France's Sarkozy says prison a 'nightmare' as prosecutors seek his release
-
Guinness maker Diageo picks new CEO after US tariffs cloud
-
China suspends 'special port fees' on US vessels
-
US senators take major step toward ending record shutdown
-
Typhoon Fung-wong leaves flooded Philippine towns in its wake
-
From Club Med to Beverly Hills: Assinie, the Ivorian Riviera
-
The 'ordinary' Arnie? Glen Powell reboots 'The Running Man'
-
Typhoon exposes centuries-old shipwreck off Vietnam port
-
French court to decide if ex-president Sarkozy can leave jail
-
China lifts sanctions on US units of South Korea ship giant Hanwha
-
Japan death row inmate's sister still fighting, even after release
-
Taylor sparks Colts to Berlin win as Pats streak hits seven
-
Dreyer, Pellegrino lift San Diego to 4-0 MLS Cup playoff win over Portland
-
Indonesia names late dictator Suharto a national hero
-
Fourth New Zealand-West Indies T20 washed out
-
Tanzania Maasai fear VW 'greenwashing' carbon credit scheme
-
Chinese businesswoman faces jail after huge UK crypto seizure
-
Markets boosted by hopes for deal to end US shutdown
-
Amazon poised to host toughest climate talks in years
-
Ex-jihadist Syrian president due at White House for landmark talks
-
Saudi belly dancers break taboos behind closed doors
-
The AI revolution has a power problem
-
Big lips and botox: In Trump's world, fashion and makeup get political
-
NBA champion Thunder rally to down Grizzlies
-
US senators reach deal that could end record shutdown
-
Weakening Typhoon Fung-wong exits Philippines after displacing 1.4 million
-
Lenny Wilkens, Basketball Hall of Famer as player and coach, dies
-
Nexscient(R) and Tekcapital Form Strategic Alliance to Accelerate AI-Driven Technology Acquisitions
-
BeenVerified People Search Tool Reunites a Family in Crisis
-
Medical Care Technologies Inc. (OTC PINK:MDCE) Marches Forward with Breakthrough Patent-Pending AI Healthcare Solutions using Smart Devices
-
Telecom Argentina S.A. Announces Consolidated Results for The Nine-Month Period ("9M25") and Third Quarter of Fiscal Year 2025 ("3Q25")
-
HWAL Inc., to Collaborate with International Music Industry Veterans on K-Pop Music Venture
-
Lir Life Sciences Corp. Formerly Blackbird Critical Metals Corp. Announces Closing of Acquisition of Lir Life Sciences Inc.
-
Luminar Media Group Delivers Record Results as Fortun Platform Scales Profitably
-
Avante Health Solutions Partners with Industry Leader Chronos Imaging LLC
-
CXAI and Noro Announce Intent to Form Strategic Collaboration to Transform Hybrid Work with Agentic AI and Immersive Presence
-
World-Renowned Artist DeWitt Fleming Jr. Visits With Students at Maple Bear Angola
-
APEX Entertainment Doubles Down On Syracuse Lacrosse With Ashlee Volpe & Joey Spallina
-
IGC Pharma to Host Mid-Year Fiscal 2026 Shareholder Update Call on November 17, 2025
America's Fauci to retire by end of Biden's current term
Anthony Fauci, who has helmed the United States' response to infectious disease outbreaks since the 1980s, will retire by the end of President Joe Biden's current term, he said in interviews Monday.
The 81-year-old told Politico and CNN he would step down from his position as director of the National Institute of Allergy and Infectious Diseases (NIAID) to pursue other avenues sometime before January 2025.
"Obviously, you can't go on forever. I do want to do other things in my career, even though I'm at a rather advanced age," Fauci, who is also Biden's chief medical advisor, said to CNN.
He told Politico he did not plan to stay in office long enough to see out Covid-19 because the disease was not going away soon.
"I think we're going to be living with this," said Fauci, who was appointed director of the National Institutes of Health's NIAID in 1984 and has served under seven presidents.
When Covid first spread globally from China, he became a trusted source of reliable information, reassuring the public with his calm and professorial demeanor during frequent media appearances.
But his honest takes on America's failures to get to grips with the virus brought Fauci into conflict with former president Donald Trump, and turned the physician-scientist into a hated figure for some on the right.
Fauci now lives with security protection after his family received death threats and harassment.
But he was conciliatory toward his former nemesis Trump in his Politico interview.
"We developed an interesting relationship," said the Italian-American.
"Two guys from New York, different in their opinions and their ideology, but still, two guys who grew up in the same environments of this city. I think that we are related to each other in that regard."
During the 1980s, Fauci became a lightning rod for criticism that the government was not doing enough to stem the rise of HIV-AIDS -- but later forged a close collaboration with activists.
His accomplishments include implementing a fast-track system that widened access to antiretroviral medicines, and working with former president George H.W. Bush to plough in more resources.
Under president George W. Bush, Fauci was the architect of the President's Emergency Plan For AIDS Relief (PEPFAR), credited with saving millions of lives in sub-Saharan Africa.
As a scientist, he is credited with developing effective treatments for formerly fatal inflammatory diseases, as well as for contributions into understanding how HIV destroys the body's defenses.
Despite his many duties, he continues to treat patients at the NIH's Clinical Center in Bethesda, Maryland.
Ch.Havering--AMWN